{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:09:07Z","timestamp":1783346947361,"version":"3.54.6"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,27]],"date-time":"2013-07-27T00:00:00Z","timestamp":1374883200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-244x-13-198","type":"journal-article","created":{"date-parts":[[2013,7,27]],"date-time":"2013-07-27T06:14:54Z","timestamp":1374905694000},"source":"Crossref","is-referenced-by-count":21,"title":["Prescribing trends of antipsychotics in youth receiving income assistance: results from a retrospective population database study"],"prefix":"10.1186","volume":"13","author":[{"given":"Andrea L","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charmaine","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Kisely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan P","family":"Kutcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,27]]},"reference":[{"issue":"8","key":"1384_CR1","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1176\/appi.ps.56.8.904","volume":"56","author":"RR Aparasu","year":"2005","unstructured":"Aparasu RR, Bhatara V: Antipsychotic prescribing trends among youths, 1997-2002. Psychiatr Serv. 2005, 56 (8): 904-10.1176\/appi.ps.56.8.904.","journal-title":"Psychiatr Serv"},{"issue":"1","key":"1384_CR2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/070674371205700109","volume":"57","author":"S Alessi-Severini","year":"2012","unstructured":"Alessi-Severini S, Biscontri RG, Collins DM, Sareen J, Enns MW: Ten years of antipsychotic prescribing to children: a Canadian population-based study. Can J Psychiatr. 2012, 57 (1): 52-58.","journal-title":"Can J Psychiatr"},{"issue":"1","key":"1384_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1185\/030079906X158075","volume":"23","author":"RR Aparasu","year":"2007","unstructured":"Aparasu RR, Bhatara V: Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004. Curr Med Res Opin. 2007, 23 (1): 49-56. 10.1185\/030079906X158075.","journal-title":"Curr Med Res Opin"},{"key":"1384_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/archpedi.158.8.753","volume":"158","author":"WO Cooper","year":"2004","unstructured":"Cooper WO, Hickson GB, Fuchs C, Arbogast PG, Ray WA: New users of antipsychotic medications among children enrolled in TennCare. Arch Pediatr Adolesc Med. 2004, 158: 753-759. 10.1001\/archpedi.158.8.753.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"1384_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ambp.2005.11.002","volume":"6","author":"WO Cooper","year":"2006","unstructured":"Cooper WO, Arbogast PG, Ding H, Hickson GB, Fuchs DC, Ray WA: Trends in prescribing of antipsychotic medications for US children. Ambul Pediatr. 2006, 6 (2): 79-83. 10.1016\/j.ambp.2005.11.002.","journal-title":"Ambul Pediatr"},{"issue":"8","key":"1384_CR6","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1176\/appi.ps.52.8.1081","volume":"52","author":"R Goodwin","year":"2001","unstructured":"Goodwin R, Gould MS, Blanco C, Olfson M: Prescription of psychotropic medications to youths in office-based practice. Psychiatr Serv. 2001, 52 (8): 1081-1087. 10.1176\/appi.ps.52.8.1081.","journal-title":"Psychiatr Serv"},{"issue":"SupplA","key":"1384_CR7","first-page":"6A","volume":"8","author":"LA Khaled","year":"2003","unstructured":"Khaled LA, Ahmed F, Brogan T, Fearnley J, Graham J, MacLeod S, McCormack J: Prescription medicine use by one million Canadian children. Paedetr Child Health. 2003, 8 (SupplA): 6A-56A.","journal-title":"Paedetr Child Health"},{"issue":"3","key":"1384_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1089\/104454602760386905","volume":"12","author":"NC Patel","year":"2002","unstructured":"Patel NC, Sanchez RJ, Johnsrud MT, Crismon ML: Trends in antipsychotic use in a Texas Medicaid population of children and adolescents: 1996 to 2000. J Child Adolesc Psychopharmacol. 2002, 12 (3): 221-229. 10.1089\/104454602760386905.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"8","key":"1384_CR9","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jama.283.8.1025","volume":"283","author":"JM Zito","year":"2000","unstructured":"Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F: Trends in the prescribing of psychotropic medications to preschoolers. JAMA. 2000, 283 (8): 1025-1030. 10.1001\/jama.283.8.1025.","journal-title":"JAMA"},{"issue":"2","key":"1384_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00004583-199802000-00010","volume":"37","author":"JM Zito","year":"1998","unstructured":"Zito JM, Safer DJ, dosReis S, Riddle MA: Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland. J Am Acad Child Adolesc Psychiatr. 1998, 37 (2): 179-184. 10.1097\/00004583-199802000-00010.","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"issue":"2","key":"1384_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/cap.1998.8.99","volume":"8","author":"JM Zito","year":"1998","unstructured":"Zito JM, Safer DJ, Riddle MA, Johnson RE, Speedie SM, Fox M: Prevalence variations in psychotropic treatment of children. J Child Adolesc Psychopharmacol. 1998, 8 (2): 99-105. 10.1089\/cap.1998.8.99.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"9","key":"1384_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.euroneuro.2009.04.008","volume":"19","author":"B Vitiello","year":"2009","unstructured":"Vitiello B, Correll C, van Zwieten-Boot B, Zuddas A, Parellada M, Arango C: Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns. Eur Neuropsychopharmacol. 2009, 19 (9): 629-635. 10.1016\/j.euroneuro.2009.04.008.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"1384_CR13","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.1542\/peds.108.2.e25","volume":"108","author":"E Schirm","year":"2001","unstructured":"Schirm E, Tobi H, Zito JM, den Berg LT d J-v: Psychotropic medication in children: a study from the Netherlands. Pediatrics. 2001, 108 (2): E25-10.1542\/peds.108.2.e25.","journal-title":"Pediatrics"},{"issue":"6","key":"1384_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/cap.2010.0145","volume":"21","author":"T Pringsheim","year":"2011","unstructured":"Pringsheim T, Lam D, Patten SB: The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005-2009. J Child Adolesc Psychopharmacol. 2011, 21 (6): 537-543. 10.1089\/cap.2010.0145.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"1384_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1345\/aph.1G203","volume":"40","author":"NC Patel","year":"2006","unstructured":"Patel NC, Crismon ML, Shafer A: Diagnoses and antipsychotic treatment among youths in a public mental health system. Ann Pharmacother. 2006, 40 (2): 205-211. 10.1345\/aph.1G203.","journal-title":"Ann Pharmacother"},{"issue":"2","key":"1384_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1089\/cap.2005.15.270","volume":"15","author":"NC Patel","year":"2005","unstructured":"Patel NC, Crismon ML, Hoagwood K, Jensen PS: Unanswered questions regarding atypical antipsychotic use in aggressive children and adolescents. J Child Adolesc Psychopharmacol. 2005, 15 (2): 270-284. 10.1089\/cap.2005.15.270.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"1384_CR17","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/01.chi.0000157543.74509.c8","volume":"44","author":"NC Patel","year":"2005","unstructured":"Patel NC, Crismon ML, Hoagwood K, Johnsrud MT, Rascati KL, Wilson JP, Jensen PS: Trends in the use of typical and atypical antipsychotics in children and adolescents. J Am Acad Child Adolesc Psychiatr. 2005, 44 (6): 548-556. 10.1097\/01.chi.0000157543.74509.c8.","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"issue":"1","key":"1384_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/oxfordjournals.schbul.a006913","volume":"28","author":"E Pappadopulos","year":"2002","unstructured":"Pappadopulos E, Jensen PS, Schur SB, MacIntyre JC, Ketner S, Van Orden K, Sverd J, Sardana S, Woodlock D, Schweitzer R, Rube D: \"Real world\" atypical antipsychotic prescribing practices in public child and adolescent inpatient settings. Schizophr Bull. 2002, 28 (1): 111-121. 10.1093\/oxfordjournals.schbul.a006913.","journal-title":"Schizophr Bull"},{"issue":"2","key":"1384_CR19","first-page":"124","volume":"19","author":"C Panagiotopoulos","year":"2010","unstructured":"Panagiotopoulos C, Ronsley R, Elbe D, Davidson J, Smith DH: First do no harm: promoting an evidence-based approach to atypical antipsychotic use in children and adolescents. J Can Acad Child Adolesc Psychiatr. 2010, 19 (2): 124-137.","journal-title":"J Can Acad Child Adolesc Psychiatr"},{"issue":"6","key":"1384_CR20","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1001\/archpsyc.63.6.679","volume":"63","author":"M Olfson","year":"2006","unstructured":"Olfson M, Blanco C, Liu L, Moreno C, Laje G: National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatr. 2006, 63 (6): 679-685. 10.1001\/archpsyc.63.6.679.","journal-title":"Arch Gen Psychiatr"},{"issue":"2","key":"1384_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1176\/ps.50.2.171","volume":"50","author":"RP Malone","year":"1999","unstructured":"Malone RP, Sheikh R, Zito JM: Novel antipsychotic medications in the treatment of children and adolescents. Psychiatr Serv. 1999, 50 (2): 171-174.","journal-title":"Psychiatr Serv"},{"issue":"7","key":"1384_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2165\/00002018-200730070-00002","volume":"30","author":"M Harrison-Woolrych","year":"2007","unstructured":"Harrison-Woolrych M, Garcia-Quiroga J, Ashton J, Herbison P: Safety and usage of atypical antipsychotic medicines in children: a nationwide prospective cohort study. Drug Saf. 2007, 30 (7): 569-579. 10.2165\/00002018-200730070-00002.","journal-title":"Drug Saf"},{"key":"1384_CR23","unstructured":"Procedures for obtaining access to PHRU data. http:\/\/www.phru.dal.ca\/services\/guidelines.cfm ,"},{"key":"1384_CR24","volume-title":"Collaborating Centre for Drug Statistics and Methodology. ATC\/DDD Index","author":"WHO","year":"2013","unstructured":"WHO: Collaborating Centre for Drug Statistics and Methodology. ATC\/DDD Index. 2013, http:\/\/www.whocc.no\/atc_ddd_index\/ ,"},{"issue":"8","key":"1384_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s001270050248","volume":"35","author":"D Lawrence","year":"2000","unstructured":"Lawrence D, Jablensky AV, Holman CD, Pinder TJ: Mortality in Western Australian psychiatric patients. Soc Psychiatr Psychiatr Epidemiol. 2000, 35 (8): 341-347. 10.1007\/s001270050248.","journal-title":"Soc Psychiatr Psychiatr Epidemiol"},{"issue":"6","key":"1384_CR26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","volume":"167","author":"DM Gardner","year":"2010","unstructured":"Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ: International consensus study of antipsychotic dosing. Am J Psychiatr. 2010, 167 (6): 686-693. 10.1176\/appi.ajp.2009.09060802.","journal-title":"Am J Psychiatr"},{"issue":"7","key":"1384_CR27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/pch\/16.7.388","volume":"16","author":"S Kutcher","year":"2011","unstructured":"Kutcher S, McLuckie A: Evergreen: A child and youth mental health framework for Canada. Paediatr Child Health. 2011, 16 (7): 388-","journal-title":"Paediatr Child Health"},{"key":"1384_CR28","volume-title":"Safe and effective medicines for children: pediatric studies conducted under the best pharmaceuticals for children act and the pediatric research equity act","author":"Institute of Medicine","year":"2012","unstructured":"Institute of Medicine: Safe and effective medicines for children: pediatric studies conducted under the best pharmaceuticals for children act and the pediatric research equity act. 2012, Washington, DC: The National Academic Press"},{"issue":"12","key":"1384_CR29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/070674371205701202","volume":"57","author":"SB Patten","year":"2012","unstructured":"Patten SB, Waheed W, Bresee L: A review of pharmacoepidemiologic studies of antipsychotic use in children and adolescents. Can J Psychiatr. 2012, 57 (12): 717-721.","journal-title":"Can J Psychiatr"},{"issue":"12","key":"1384_CR30","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/070674371005501202","volume":"55","author":"D Lawrence","year":"2010","unstructured":"Lawrence D, Kisely S, Pais J: The epidemiology of excess mortality in people with mental illness. Can J Psychiatr. 2010, 55 (12): 752-760.","journal-title":"Can J Psychiatr"},{"issue":"12","key":"1384_CR31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/070674371005501201","volume":"55","author":"S Kisely","year":"2010","unstructured":"Kisely S: Excess mortality from chronic physical disease in psychiatric patients-the forgotten problem. Can J Psychiatr. 2010, 55 (12): 749-751.","journal-title":"Can J Psychiatr"},{"issue":"6","key":"1384_CR32","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1192\/bjp.bp.109.067082","volume":"195","author":"S Kisely","year":"2009","unstructured":"Kisely S, Campbell LA, Wang Y: Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare. Br J Psychiatr. 2009, 195 (6): 545-550. 10.1192\/bjp.bp.109.067082.","journal-title":"Br J Psychiatr"},{"issue":"4","key":"1384_CR33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/070674370905400408","volume":"54","author":"S Kisely","year":"2009","unstructured":"Kisely S, Cox M, Campbell LA, Cooke C, Gardner D: An epidemiologic study of psychotropic medication and obesity-related chronic illnesses in older psychiatric patients. Can J Psychiatr. 2009, 54 (4): 269-274.","journal-title":"Can J Psychiatr"},{"issue":"2","key":"1384_CR34","first-page":"177","volume":"31","author":"S Kisely","year":"1997","unstructured":"Kisely S, Guthrie E, Creed F, Tew R: Predictors of mortality and morbidity following admission with chest pain. J R Coll Physicians Lond. 1997, 31 (2): 177-183.","journal-title":"J R Coll Physicians Lond"},{"issue":"11","key":"1384_CR35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/070674370805301107","volume":"53","author":"S Kisely","year":"2008","unstructured":"Kisely S, Sadek J, MacKenzie A, Lawrence D, Campbell LA: Excess cancer mortality in psychiatric patients. Can J Psychiatr. 2008, 53 (11): 753-761.","journal-title":"Can J Psychiatr"},{"issue":"6","key":"1384_CR36","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1503\/cmaj.060482","volume":"176","author":"S Kisely","year":"2007","unstructured":"Kisely S, Smith M, Lawrence D, Cox M, Campbell LA, Maaten S: Inequitable access for mentally ill patients to some medically necessary procedures. CMAJ. 2007, 176 (6): 779-784.","journal-title":"CMAJ"},{"key":"1384_CR37","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1192\/bjp.187.6.552","volume":"187","author":"S Kisely","year":"2005","unstructured":"Kisely S, Smith M, Lawrence D, Maaten S: Mortality in individuals who have had psychiatric treatment: population-based study in Nova Scotia. Br J Psychiatr. 2005, 187: 552-558. 10.1192\/bjp.187.6.552.","journal-title":"Br J Psychiatr"},{"issue":"2","key":"1384_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3109\/00048679809062726","volume":"32","author":"SR Kisely","year":"1998","unstructured":"Kisely SR: The relationship between admission to hospital with chest pain and psychiatric disorder. Aust N Z J Psychiatr. 1998, 32 (2): 172-179. 10.3109\/00048679809062726.","journal-title":"Aust N Z J Psychiatr"},{"issue":"3","key":"1384_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1192\/bjp.bp.110.081695","volume":"199","author":"S Kisely","year":"2011","unstructured":"Kisely S, Quek LH, Pais J, Lalloo R, Johnson NW, Lawrence D: Advanced dental disease in people with severe mental illness: systematic review and meta-analysis. Br J Psychiatr. 2011, 199 (3): 187-193. 10.1192\/bjp.bp.110.081695.","journal-title":"Br J Psychiatr"},{"issue":"4","key":"1384_CR40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1017\/S1121189X00002141","volume":"15","author":"R Mangalore","year":"2006","unstructured":"Mangalore R, Knapp M: Equity in mental health. Epidemiol Psichiatr Soc. 2006, 15 (4): 260-266. 10.1017\/S1121189X00002141.","journal-title":"Epidemiol Psichiatr Soc"},{"issue":"9590","key":"1384_CR41","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0140-6736(07)61239-2","volume":"370","author":"S Saxena","year":"2007","unstructured":"Saxena S, Thornicroft G, Knapp M, Whiteford H: Resources for mental health: scarcity, inequity, and inefficiency. Lancet. 2007, 370 (9590): 878-889. 10.1016\/S0140-6736(07)61239-2.","journal-title":"Lancet"},{"issue":"9","key":"1384_CR42","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1176\/appi.ps.52.9.1245","volume":"52","author":"CS Dewa","year":"2001","unstructured":"Dewa CS, Goering P: Lessons learned from trends in psychotropic drug expenditures in a canadian province. Psychiatr Serv. 2001, 52 (9): 1245-1247. 10.1176\/appi.ps.52.9.1245.","journal-title":"Psychiatr Serv"},{"issue":"9","key":"1384_CR43","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/S0149-2918(02)80050-9","volume":"24","author":"CS Dewa","year":"2002","unstructured":"Dewa CS, Remington G, Herrmann N, Fearnley J, Goering P: How much are atypical antipsychotic agents being used, and do they reach the populations who need them? A Canadian experience. Clin Ther. 2002, 24 (9): 1466-1476. 10.1016\/S0149-2918(02)80050-9.","journal-title":"Clin Ther"},{"issue":"1","key":"1384_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/oxfordjournals.schbul.a006995","volume":"29","author":"ME Domino","year":"2003","unstructured":"Domino ME, Frank RG, Rosenheck R: The Diffusion of New Antipsychotic Medications and Formulary Policy. Schizophr Bull. 2003, 29 (1): 95-104. 10.1093\/oxfordjournals.schbul.a006995.","journal-title":"Schizophr Bull"},{"issue":"2","key":"1384_CR45","first-page":"e346","volume":"16","author":"DJ O'Reilly","year":"2009","unstructured":"O'Reilly DJ, Goeree RA, Tarride JE, James C, Parfrey PS: The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996\/97 to 2005\/06. Can J Clin Pharmacol. 2009, 16 (2): e346-e359.","journal-title":"Can J Clin Pharmacol"},{"key":"1384_CR46","unstructured":"BC Children's Hospital: Provincial Mental Health Metabolic Program. http:\/\/www.bcchildrens.ca\/Services\/ChildYouthMentalHlth\/ProgramsAndServices\/ProvMHMetabolicProg\/default.htm ,"},{"issue":"3","key":"1384_CR47","first-page":"218","volume":"20","author":"T Pringsheim","year":"2011","unstructured":"Pringsheim T, Panagiotopoulos C, Davidson J, Ho J, CAMESA guideline group: Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth. J Can Acad Child Adolesc Psychiatr. 2011, 20 (3): 218-233.","journal-title":"J Can Acad Child Adolesc Psychiatr"},{"key":"1384_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1874944500902010011","volume":"2","author":"K Ferver","year":"2009","unstructured":"Ferver K, Burton B, Jesilow P: The use of claims data in healthcare research. Open Publ Health J. 2009, 2: 11-24. 10.2174\/1874944500902010011.","journal-title":"Open Publ Health J"},{"issue":"17","key":"1384_CR49","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1503\/cmaj.110749","volume":"183","author":"LY Katz","year":"2011","unstructured":"Katz LY, Au W, Singal D, Brownell M, Roos N, Martens PJ, Chateau D, Enns MW, Kozyrskyj AL, Sareen J: Suicide and suicide attempts in children and adolescents in the child welfare system. CMAJ. 2011, 183 (17): 1977-1981.","journal-title":"CMAJ"},{"key":"1384_CR50","volume-title":"FDA Approves Risperdal for Two Psychiatric Conditions in Children and Adolescents","author":"U.S. Food and Drug Administration","year":"2007","unstructured":"U.S. Food and Drug Administration: FDA Approves Risperdal for Two Psychiatric Conditions in Children and Adolescents. 2007, http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2007\/ucm108969.htm ,"},{"issue":"1","key":"1384_CR51","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1753-2000-2-26","volume":"2","author":"JM Zito","year":"2008","unstructured":"Zito JM, Safer DJ, de Jong-van den Berg LT, Janhsen K, Fegert JM, Gardner JF, Glaeske G, Valluri SC: A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatr Ment Health. 2008, 2 (1): 26-10.1186\/1753-2000-2-26.","journal-title":"Child Adolesc Psychiatr Ment Health"},{"issue":"11","key":"1384_CR52","first-page":"1442","volume":"52","author":"B Maheux","year":"2006","unstructured":"Maheux B, Gilbert A, Haley N, Frappier JY: Adolescent care. Part 2: communication and referral practices of family physicians caring for adolescents with mental health problems. Can Fam Physician. 2006, 52 (11): 1442-1443.","journal-title":"Can Fam Physician"},{"issue":"2","key":"1384_CR53","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-2753.2010.01597.x","volume":"18","author":"MJ Fleury","year":"2012","unstructured":"Fleury MJ, Bamvita JM, Farand L, Aube D, Fournier L, Lesage A: GP group profiles and involvement in mental health care. J Eval Clin Pract. 2012, 18 (2): 396-403. 10.1111\/j.1365-2753.2010.01597.x.","journal-title":"J Eval Clin Pract"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-13-198\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T20:00:19Z","timestamp":1563566419000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-13-198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,27]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1384"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-13-198","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,27]]},"article-number":"198"}}